AKT2 and breast cancer: Moreover, anchorage-independent growth and invasion were significantly reduced also in breast cancer cell lines with clear mesenchymal phenotype; with high expression of ALDH1A1, (MDA-MB-468 and SKBR3) after AKT2 silencing (Figure S7A,B).